WELL Health Technologies Future Growth
Future criteria checks 1/6
WELL Health Technologies's earnings are forecast to decline at 17.4% per annum while its annual revenue is expected to grow at 9.3% per year. EPS is expected to grow by 3.6% per annum.
Key information
-17.4%
Earnings growth rate
3.6%
EPS growth rate
| Healthcare earnings growth | 61.6% |
| Revenue growth rate | 9.3% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?
Nov 11
Is WELL Health Technologies (TSE:WELL) A Risky Investment?
Sep 09Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher
Jul 05WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price
Jun 11WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem
May 21WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Mar 21Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?
Feb 29The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)
Jan 18WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Oct 30We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt
Jul 17WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Apr 18Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?
Jan 13Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?
Nov 11Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?
Aug 09WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price
May 31Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,191 | 39 | 100 | 128 | 4 |
| 12/31/2025 | 1,098 | 9 | 79 | 121 | 15 |
| 12/31/2024 | 988 | 46 | 78 | 185 | 15 |
| 9/30/2024 | 958 | 73 | 112 | 127 | N/A |
| 6/30/2024 | 910 | 147 | 67 | 89 | N/A |
| 3/31/2024 | 838 | 30 | 49 | 68 | N/A |
| 12/31/2023 | 776 | 0 | 41 | 66 | N/A |
| 9/30/2023 | 701 | -7 | 60 | 81 | N/A |
| 6/30/2023 | 643 | -4 | 61 | 76 | N/A |
| 3/31/2023 | 612 | -5 | 67 | 81 | N/A |
| 12/31/2022 | 569 | 1 | 70 | 77 | N/A |
| 9/30/2022 | 528 | -29 | 20 | 56 | N/A |
| 6/30/2022 | 482 | -37 | 5 | 49 | N/A |
| 3/31/2022 | 403 | -45 | -19 | 34 | N/A |
| 12/31/2021 | 302 | -44 | -30 | 22 | N/A |
| 9/30/2021 | 204 | -29 | -13 | 10 | N/A |
| 6/30/2021 | 117 | -21 | -10 | 2 | N/A |
| 3/31/2021 | 66 | -9 | -4 | -4 | N/A |
| 12/31/2020 | 50 | -4 | -7 | -5 | N/A |
| 9/30/2020 | 43 | -9 | -5 | -4 | N/A |
| 6/30/2020 | 39 | -10 | -4 | -3 | N/A |
| 3/31/2020 | 36 | -8 | -4 | -3 | N/A |
| 12/31/2019 | 33 | -8 | -3 | -3 | N/A |
| 12/31/2018 | 9 | -2 | -1 | -1 | N/A |
| 10/31/2018 | 6 | -2 | -1 | -1 | N/A |
| 7/31/2018 | 4 | -6 | N/A | -1 | N/A |
| 4/30/2018 | 2 | -6 | N/A | -1 | N/A |
| 1/31/2018 | 0 | -6 | N/A | -1 | N/A |
| 10/31/2017 | N/A | -1 | N/A | -1 | N/A |
| 7/31/2017 | 0 | -1 | N/A | -1 | N/A |
| 3/31/2017 | 0 | 0 | N/A | -1 | N/A |
| 12/31/2016 | 0 | 0 | N/A | 0 | N/A |
| 10/31/2016 | 0 | -1 | N/A | 0 | N/A |
| 12/31/2015 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WELL's earnings are forecast to decline over the next 3 years (-17.4% per year).
Earnings vs Market: WELL's earnings are forecast to decline over the next 3 years (-17.4% per year).
High Growth Earnings: WELL's earnings are forecast to decline over the next 3 years.
Revenue vs Market: WELL's revenue (9.3% per year) is forecast to grow faster than the Canadian market (7.1% per year).
High Growth Revenue: WELL's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WELL's Return on Equity is forecast to be high in 3 years time